Video
Dr. Eure on BPH medications and increased risk of heart failure
Author(s):
Video Player is loading.
Gregg Eure, MD, FACS, Urology of Virginia, discusses the increased of heart failure associated with medications for the treatment of patients with benign prostatic hyperplasia (BPH). A recently published study showed an increased risk of cardiac failure in men with BPH and exposure to 5-alpha reductase inhibitors and/or α-blockers.
Related Videos
BPH Treatment and Impact on Sexual Health
Clinical Benefits of BPH Treatments
BPH Management: Patient Outcome Evolution
Resective Surgery and Minimally Invasive Procedures For BPH
Naeem Bhojani, MD, expands on key findings from WATER III trial
Naeem Bhojani, MD, discusses WATER III data on Aquablation vs enucleation for BPH
BPH: The Patient Journey
Amy E. Krambeck, MD, on what’s needed to improve safety, efficacy of HoLEP
The role of preoperative imaging with HoLEP for BPH
Incorporating emerging technologies into HoLEP for BPH
Related Content
